Texas Medicaid Moving Away From Acquisition Cost Billing for 340B Drugs

by Admin | January 29, 2014 11:16 am

January 29, 2014—Texas Medicaid proposes to stop requiring health care providers to bill it for 340B drugs at actual acquisition cost (AAC) and to begin reimbursing providers instead based on its best estimate of a drug’s 340B price plus a dispensing fee.  

You must be registered to read complete articles (it's quick, easy, and 100% free). Click here to register[1].    Already registered? Click here to login[2]. (340B Health members, Drug Discount Monitor subscribers, and 340B Coalition conference attendees: Use your existing username and password.)

Endnotes:
  1. Click here to register: https://secure.340bhealth.org/340Binformed/Subscribe.aspx
  2. Click here to login: http://340binformed.org/reader-login/

Source URL: https://340binformed.org/2014/01/texas-medicaid-moving-away-from-acquisition-cost-billing-for-340b-drugs/

Copyright ©2024 340binformed.org unless otherwise noted.